The president’s proposed 25 percent tariffs on pharmaceutical imports will be catastrophic. There are other options to bring ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

MoonLake Immunotherapeutics' Sonelokimab's Phase 3 trials, PsA market growth, and Merck's $3B bid showcase potential. Read my ...

As a sales rep for drug manufacturers Questcor, Lisa Pratta always suspected the company’s business practices weren’t just ...

The size of India’s insulin market was an estimated Rs 4,404 crore in April this year, with Indian players making steady ...

Research modelling the effect of U.S. prices for patented medicines if they are equal to or less than Canada’s shows prices ...

The widespread hunt for candidates who are equally versed in tech and healthcare is making AI recruiting a challenge.

Learn about May 2025’s top biotech deals, featuring major collaborations in RNA interference technology, small molecules, and ...

The American Society for Clinical Oncology’s Annual Meeting for 2025 is, if nothing else, absolutely overwhelming and ...

A February executive order on pharmaceutical price transparency does nothing to change the incentives that keep costs opaque.

Kymera Therapeutics reported positive results from its phase 1 healthy volunteer study using KT-621. Click here to find out ...

Novo Nordisk has filed a lawsuit in Delhi High Court. The suit aims to stop Dr Reddy's Laboratories and OneSource from ...